Design, modeling and 3D printing of a personalized cervix tissue implant with protein release function
Fabrication and characterization of double-layer asymmetric dressing through electrostatic spinning and 3D printing for skin wound repair
Human Papillomavirus (HPV) Entry Inhibitors
Clinical research in recombinant human type Ⅲ collagen- derived vaginal gel in the treatment of vaginal
Injectable recombinant human collagen-derived material with high cell adhesion activity limits adverse remodelling and improves pelvic floor function in pelvic floor dysfunction rats
Intravaginal Administration of Human Type III Collagen-Derived Biomaterial with High Cell-Adhesion Activity to Treat Vaginal Atrophy in Rats
A tailored extracellular matrix (ECM) - Mimetic coating for cardiovascular stents by stepwise assembly of hyaluronic acid and recombinant human type III collagen
Microenvironment-responsive multifunctional hydrogels with spatiotemporal sequential release of tailored recombinant human collagen type III for the rapid repair of infected chronic diabetic wounds
Dissolving microneedle-encapsulated drug-loaded nanoparticles and recombinant humanized collagen type III for the treatment of chronic wound via anti-inflammation and enhanced cell proliferation and angiogenesis
A strategy of functional crosslinking acellular matrix in blood-contacting implantable devices with recombinant humanized collagen type III (rhCOLIII)
Microfibrillated cellulose-enhanced carboxymethyl chitosan_oxidized starch sponge for chronic diabetic wound repair
The biological effect of recombinant humanized collagen on damaged skin induced by UV-photoaging：An in vivo study
Developmentof innovative biomaterials and devices for the treatment of cardiovascular diseases
Injectable multifunctional hyaluronic acid_ methylcellulose hydrogels for chronic wounds repairing
Regeneration of infarcted hearts by myocardial infarction-responsive injectable hydrogels with combined anti-apoptosis, anti-inflammatory and pro-angiogenesis properties
Bovine β-lactoglobulin modified by 3-hydroxyphthalic anhydride blocks the CD4 cell receptor for HIV
Chemically modified bovine beta-lactoglobulin inhibits human papillomavirus infection
Repurposing of a clinically used anti-HPV agent to prevent and treat SARS-CoV-2 infection as an intranasal formulation
A randomized open-label clinical trial of an anti-HPV biological dressing(JB01-BD) administered intravaginally to treat high-risk HPV infection
Safety Evaluation of Chemically Modified Beta-Lactoglobulin Administered Intravaginally
A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike
Characterization by high-resolution crystal structure analysis of a triple-helix region of human collagen type III with potent cell adhesion activity
The Underlying Mechanism of 3-Hydroxyphthalic Anhydride Modified Bovine Beta-Lactoglobulin to Block Human Papillomavirus Entry Into the Host Cell
